$4.97 Billion is the total value of PFM Health Sciences, LP's 61 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRK | Exit | MERCK & CO INC NEWcall | $0 | – | -458,700 | -100.0% | -0.00% | – |
| MYGN | Exit | MYRIAD GENETICS INCcall | $0 | – | -194,000 | -100.0% | -0.00% | – |
| RPRX | Exit | REPROS THERAPEUTICS INCcall | $0 | – | -168,800 | -100.0% | -0.00% | – |
| WAT | Exit | WATERS CORPcall | $0 | – | -329,600 | -100.0% | -0.01% | – |
| WAT | Exit | WATERS CORP | $0 | – | -43,054 | -100.0% | -0.11% | – |
| SIRO | Exit | SIRONA DENTAL SYSTEMS INC | $0 | – | -70,697 | -100.0% | -0.11% | – |
| AGIO | Exit | AGIOS PHARMACEUTICALS INC | $0 | – | -206,829 | -100.0% | -0.14% | – |
| GNMK | Exit | GENMARK DIAGNOSTICS INC | $0 | – | -650,015 | -100.0% | -0.19% | – |
| MYL | Exit | MYLAN INC | $0 | – | -233,887 | -100.0% | -0.22% | – |
| MOH | Exit | MOLINA HEALTHCARE INC | $0 | – | -250,989 | -100.0% | -0.22% | – |
| GPORQ | Exit | GULFPORT ENERGY CORP | $0 | – | -139,329 | -100.0% | -0.22% | – |
| RAD | Exit | RITE AID CORP | $0 | – | -1,884,889 | -100.0% | -0.22% | – |
| CFN | Exit | CAREFUSION CORP | $0 | – | -246,921 | -100.0% | -0.22% | – |
| ACT | Exit | ACTAVIS INC | $0 | – | -66,659 | -100.0% | -0.23% | – |
| EPZM | Exit | EPIZYME INC | $0 | – | -281,136 | -100.0% | -0.27% | – |
| LNKD | Exit | LINKEDIN CORP | $0 | – | -50,690 | -100.0% | -0.30% | – |
| 5100PS | Exit | VOLCANO CORPORATION | $0 | – | -585,302 | -100.0% | -0.34% | – |
| CI | Exit | CIGNA CORPORATION | $0 | – | -201,492 | -100.0% | -0.37% | – |
| Exit | PHH CORPnote 4.000% 9/0 | $0 | – | -14,207,000 | -100.0% | -0.37% | – | |
| CIE | Exit | COBALT INTL ENERGY INC | $0 | – | -676,703 | -100.0% | -0.40% | – |
| MRK | Exit | MERCK & CO INC NEW | $0 | – | -389,358 | -100.0% | -0.45% | – |
| YELP | Exit | YELP INCcl a | $0 | – | -348,393 | -100.0% | -0.56% | – |
| SINA | Exit | SINA CORPord | $0 | – | -402,822 | -100.0% | -0.79% | – |
| MTG | Exit | MGIC INVT CORP WIS | $0 | – | -4,547,872 | -100.0% | -0.80% | – |
| TDC | Exit | TERADATA CORP DEL | $0 | – | -674,137 | -100.0% | -0.90% | – |
| JCI | Exit | JOHNSON CTLS INC | $0 | – | -953,085 | -100.0% | -0.95% | – |
| VIPS | Exit | VIPSHOP HLDGS LTDsponsored adr | $0 | – | -705,149 | -100.0% | -0.96% | – |
| PPO | Exit | POLYPORE INTL INC | $0 | – | -1,032,923 | -100.0% | -1.02% | – |
| TEX | Exit | TEREX CORP NEW | $0 | – | -1,264,391 | -100.0% | -1.02% | – |
| SCHW | Exit | SCHWAB CHARLES CORP NEW | $0 | – | -2,125,377 | -100.0% | -1.08% | – |
| AAPL | Exit | APPLE INC | $0 | – | -107,920 | -100.0% | -1.24% | – |
| TIBX | Exit | TIBCO SOFTWARE INC | $0 | – | -2,265,712 | -100.0% | -1.40% | – |
| LOW | Exit | LOWES COS INC | $0 | – | -1,418,185 | -100.0% | -1.63% | – |
| WCRX | Exit | WARNER CHILCOTT PLC IRELAND | $0 | – | -4,538,824 | -100.0% | -2.51% | – |
| CAM | Exit | CAMERON INTERNATIONAL CORP | $0 | – | -1,813,731 | -100.0% | -2.55% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2014-02-21
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MOLINA HEALTHCARE INC | 41 | Q3 2023 | 2.2% |
| HCA HOLDINGS INC | 38 | Q3 2023 | 5.2% |
| HUMANA INC | 37 | Q3 2023 | 3.8% |
| EDWARDS LIFESCIENCES CORP | 36 | Q3 2023 | 3.3% |
| UNITEDHEALTH GROUP INC | 33 | Q3 2023 | 4.8% |
| PENUMBRA INC | 33 | Q3 2023 | 4.8% |
| AERIE PHARMACEUTICALS INC | 28 | Q2 2022 | 3.7% |
| TENET HEALTHCARE CORP | 27 | Q3 2023 | 2.3% |
| ELEVANCE HEALTH INC | 26 | Q3 2023 | 4.2% |
| ICON PLC | 26 | Q3 2023 | 2.5% |
View PFM Health Sciences, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adaptimmune Therapeutics PLC | February 14, 2023 | ? | ? |
| Arcus Biosciences, Inc. | February 14, 2023 | ? | ? |
| Axsome Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Erasca, Inc. | February 14, 2023 | ? | ? |
| Generation Bio Co. | February 14, 2023 | ? | ? |
| IO Biotech, Inc. | February 14, 2023 | ? | ? |
| Jounce Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Outset Medical, Inc. | February 14, 2023 | ? | ? |
| uniQure N.V. | February 14, 2023 | ? | ? |
| AERIE PHARMACEUTICALS INC | February 14, 2022 | ? | ? |
View PFM Health Sciences, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
View PFM Health Sciences, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.